Chemoinformaics analysis of Isobutyl vinyl ether
| Molecular Weight | 100.161 | nRot | 3 |
| Heavy Atom Molecular Weight | 88.065 | nRig | 13 |
| Exact Molecular Weight | 100.089 | nRing | 0 |
| Solubility: LogS | -6.154 | nHRing | 0 |
| Solubility: LogP | 5.061 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 19 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 7 | No. of Aromatic Carbocycles | 0 |
| nHetero | 1 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 12 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 6 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 1 | No. of Arom Bond | 0 |
| nHA | 1 | APOL | 18.8235 |
| nHD | 0 | BPOL | 13.7745 |
| QED | 0.547 |
| Synth | 5.289 |
| Natural Product Likeliness | 2.862 |
| NR-PPAR-gamma | 0.005 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.007 |
| Pgp-sub | 0 |
| HIA | 0.004 |
| CACO-2 | -4.646 |
| MDCK | 0.0000124 |
| BBB | 0.866 |
| PPB | 0.971672 |
| VDSS | 2.281 |
| FU | 0.03693 |
| CYP1A2-inh | 0.271 |
| CYP1A2-sub | 0.774 |
| CYP2c19-inh | 0.27 |
| CYP2c19-sub | 0.939 |
| CYP2c9-inh | 0.393 |
| CYP2c9-sub | 0.825 |
| CYP2d6-inh | 0.028 |
| CYP2d6-sub | 0.879 |
| CYP3a4-inh | 0.238 |
| CYP3a4-sub | 0.327 |
| CL | 16.76 |
| T12 | 0.067 |
| hERG | 0.031 |
| Ames | 0.015 |
| ROA | 0.037 |
| SkinSen | 0.701 |
| Carcinogencity | 0.053 |
| EI | 0.458 |
| Respiratory | 0.863 |
| NR-Aromatase | 0.012 |
| Antiviral | No |
| Prediction | 0.956833 |